CN106456679A - 包含含有片球菌和乳杆菌的细菌混合物的组合物和减小酒精影响的方法 - Google Patents

包含含有片球菌和乳杆菌的细菌混合物的组合物和减小酒精影响的方法 Download PDF

Info

Publication number
CN106456679A
CN106456679A CN201480026365.XA CN201480026365A CN106456679A CN 106456679 A CN106456679 A CN 106456679A CN 201480026365 A CN201480026365 A CN 201480026365A CN 106456679 A CN106456679 A CN 106456679A
Authority
CN
China
Prior art keywords
compositionss
antibacterial
mixture
powder
tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480026365.XA
Other languages
English (en)
Chinese (zh)
Inventor
R·卡彭特
A·卡普尔
E·W·哈夫
N·苏尔什
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biowish Technologies Inc
Original Assignee
Biowish Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biowish Technologies Inc filed Critical Biowish Technologies Inc
Publication of CN106456679A publication Critical patent/CN106456679A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Jellies, Jams, And Syrups (AREA)
CN201480026365.XA 2013-05-10 2014-05-12 包含含有片球菌和乳杆菌的细菌混合物的组合物和减小酒精影响的方法 Pending CN106456679A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361821974P 2013-05-10 2013-05-10
US61/821974 2013-05-10
PCT/US2014/037704 WO2014183117A1 (en) 2013-05-10 2014-05-12 Compositions comprising a mixture of bacteria comprising pedoiococcus and lactobacillus an methods for decreasing the effects of alcohols

Publications (1)

Publication Number Publication Date
CN106456679A true CN106456679A (zh) 2017-02-22

Family

ID=50980375

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480026365.XA Pending CN106456679A (zh) 2013-05-10 2014-05-12 包含含有片球菌和乳杆菌的细菌混合物的组合物和减小酒精影响的方法

Country Status (10)

Country Link
US (1) US10130664B2 (cg-RX-API-DMAC7.html)
EP (1) EP2994149A1 (cg-RX-API-DMAC7.html)
JP (1) JP6452258B2 (cg-RX-API-DMAC7.html)
KR (1) KR20160013069A (cg-RX-API-DMAC7.html)
CN (1) CN106456679A (cg-RX-API-DMAC7.html)
AU (2) AU2014262427B2 (cg-RX-API-DMAC7.html)
CA (1) CA2911947A1 (cg-RX-API-DMAC7.html)
HK (1) HK1222584A1 (cg-RX-API-DMAC7.html)
RU (1) RU2671221C2 (cg-RX-API-DMAC7.html)
WO (1) WO2014183117A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115919907A (zh) * 2021-08-31 2023-04-07 E·施约林 一种用于治疗和/或预防食物和/或酒精中毒的组合物

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170005093A (ko) 2014-05-12 2017-01-11 바이오위시 테크놀로지스, 인크. 인간 건강 및 영양 향상을 위한 조성물 및 방법
KR101853603B1 (ko) * 2017-05-18 2018-05-02 주식회사 쎌바이오텍 알코올 또는 아세트알데하이드 분해용 프로바이오틱스를 포함하는 조성물
WO2019232026A1 (en) 2018-05-29 2019-12-05 BiOWiSH Technologies, Inc. Compositions and methods for improving survivability of aquatic animals
CN109350629B (zh) * 2018-08-09 2021-06-01 新乡医学院 一种用于治疗酒精戒断综合征的益生菌复合制剂及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1853508A (zh) * 2005-04-19 2006-11-01 韩国养药多股份有限公司 有效改善肝功能、降低血液酒精浓度及加强抗氧化能力的组合物
CN1993052A (zh) * 2004-07-29 2007-07-04 京都府 植物病害防除剂和防除方法
US20110014278A1 (en) * 2005-02-07 2011-01-20 Virbac Sa Compositions Comprising Dehydrated Micro-Organisms, Method for Preparing Same, and Uses Thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998007867A2 (en) * 1996-08-22 1998-02-26 Bioteknologisk Institut Metabolically engineered lactic acid bacteria and means for providing same
US6953574B2 (en) * 2002-06-21 2005-10-11 Technology Commercialization, Inc. Method for producing a fermented hydrolyzed medium containing microorganisms
US20060263385A1 (en) 2005-05-17 2006-11-23 Fran Gare Composition to relieve side effects of alcohol intoxication
JP5413819B2 (ja) * 2008-02-08 2014-02-12 国立大学法人広島大学 肝機能改善剤およびその製造用ツール、ならびにこれらの利用
IT1392101B1 (it) 2008-12-12 2012-02-09 Zuccari Societa A Responsabilita Limitata In Breve Zuccari S R L Composizione comprendente isoflavoni
US9579353B2 (en) * 2011-06-10 2017-02-28 Prothera, Inc. Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
US9161957B2 (en) 2012-08-03 2015-10-20 Life Well Lived, Llc Compositions and methods for reducing blood alcohol content
CN104755092A (zh) * 2012-10-30 2015-07-01 雀巢产品技术援助有限公司 用于递送协同免疫作用的包含微粒和益生菌的组合物
CN102934809B (zh) * 2012-12-10 2014-04-30 济南大学 益生菌发酵中药制剂制备的组合物及其制备方法和应用

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1993052A (zh) * 2004-07-29 2007-07-04 京都府 植物病害防除剂和防除方法
US20110014278A1 (en) * 2005-02-07 2011-01-20 Virbac Sa Compositions Comprising Dehydrated Micro-Organisms, Method for Preparing Same, and Uses Thereof
CN1853508A (zh) * 2005-04-19 2006-11-01 韩国养药多股份有限公司 有效改善肝功能、降低血液酒精浓度及加强抗氧化能力的组合物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
I.A.KIRPICH ET AL.: "Probiotics restore bowel flora and improve liver enzymes in human", 《ALCOHOL》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115919907A (zh) * 2021-08-31 2023-04-07 E·施约林 一种用于治疗和/或预防食物和/或酒精中毒的组合物

Also Published As

Publication number Publication date
US10130664B2 (en) 2018-11-20
EP2994149A1 (en) 2016-03-16
AU2014262427B2 (en) 2018-12-13
CA2911947A1 (en) 2014-11-13
AU2014262427A1 (en) 2015-11-26
AU2019201637A1 (en) 2019-04-11
RU2015152826A (ru) 2017-06-20
RU2671221C2 (ru) 2018-10-30
JP2016521287A (ja) 2016-07-21
KR20160013069A (ko) 2016-02-03
HK1222584A1 (zh) 2017-07-07
JP6452258B2 (ja) 2019-01-16
US20140335187A1 (en) 2014-11-13
WO2014183117A1 (en) 2014-11-13

Similar Documents

Publication Publication Date Title
US20080102061A1 (en) Use hydrolyzed medium containing microorganisms medicinally
TW200902040A (en) Probiotics in a pre-and/or post-surgical environment
JP2009269925A (ja) Ｓｉｄｓに関連する細菌感染を処置するための共生乳酸細菌
AU2019201637A1 (en) Compositions Comprising a Mixture of Bacteria Comprising Pediococcus and Lactobacillus and Methods for Decreasing the Effects of Alcohols
CA2690058A1 (en) Fermented probiotic beverages and uses thereof
KR101940001B1 (ko) 신장 기능을 강화시키는 조성물 및 방법
JP5592640B2 (ja) 乳酸菌発酵ローヤルゼリーを含有する抗ストレス剤、その製造方法、視床下部−下垂体−副腎皮質系の活動抑制剤、及び交感神経−副腎髄質系の活動抑制剤
JP2002522393A (ja) 共生乳酸産生細菌を使用する、栄養材料の溶解度を増大するための方法
CN115120646A (zh) 一种平衡肠道菌群的益生菌组合物及其制备方法和应用
EP1916911A2 (fr) Utilisation d'un symbiotique pour le traitement de la dermatite atopique
JP2016521287A6 (ja) ペディオコッカス（Ｐｅｄｉｏｃｏｃｃｕｓ）とラクトバチルス（Ｌａｃｔｏｂａｃｉｌｌｕｓ）とを含む細菌の混合物を含む組成物、ならびにアルコールの影響を軽減するための方法
TWI642363B (zh) Ｑｏｌ改善或維持劑
CN114317367A (zh) 一种益生菌组合物、组合物的应用及辅助解酒制剂
WO2017159647A1 (ja) フィーカリバクテリウム属細菌増殖剤
ES2963547T3 (es) Tratamiento del IBS con probióticos
JP2007186529A (ja) 悪臭ガス放出減少方法
FR2906109A1 (fr) Complement alimentaire pour la prevention et la lutte contre les infections urinaires
TWI861750B (zh) 提升睡眠品質之益生菌組成物及其用途
EP2139502B1 (en) Lactobacillus and bifidobacterium against birch allergy
KR20210043519A (ko) 장내 세균총에 유익한 효능을 가진 유산균을 활용한 면역력 향상 기능성 첨가물 및 그 제조방법
CN120361196B (zh) 短双歧杆菌协同乳铁蛋白在制备调节肠道菌群或抗细菌感染产品中的应用
Code Proprietary human strain probiotic for extra daily support
TW202602432A (zh) 合生元用於製備提升類升糖素胜肽-1的組合物的用途
JP2026008765A (ja) シンバイオティクスの、グルカゴン様ペプチド－１を上昇させる組成物の調製における用途
CA2493107A1 (fr) Composition alimentaire pour maintien et retablissement des fonctions digestives

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: ohio

Applicant after: American Baowei Technology Co., Ltd.

Address before: ohio

Applicant before: BIOWISH TECHNOLOGIES INC

CB02 Change of applicant information
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170222

WD01 Invention patent application deemed withdrawn after publication